Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized [read full press release…]
Rockville, USA, 2019-May-07 — /EPR Network/ — Medical organizations as well as leaders in the global pharmaceuticals industry are stepping up their efforts towards development of profound [read full press release…]
Rockville, USA, 2019-Apr-15 — /EPR Network/ — According to a recent report by Fact.MR, the global lung cancer diagnostics market is anticipated to register 7.3% CAGR [read full press release…]
